Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus MEDLINE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Current Challenges and Long-Term Outcomes in Corneal Transplantation in Infectious Keratitis-A Systematic Review.

Title: Current Challenges and Long-Term Outcomes in Corneal Transplantation in Infectious Keratitis-A Systematic Review.
Authors: Onofrei AG; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; BINE Ophthalmology Clinic, 020483 Bucharest, Romania.; Gheorghe AG; Department of Ophthalmology, Clinical Institute of Ophthalmological Emergencies 'Prof. Dr. Mircea Olteanu', 010464 Bucharest, Romania.; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Dascalu AM; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Ophthalmology Department, Emergency University Hospital, 050098 Bucharest, Romania.; Cristea BM; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Istrate S; BINE Ophthalmology Clinic, 020483 Bucharest, Romania.; Arghirescu AM; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Department of Ophthalmology, Clinical Institute of Ophthalmological Emergencies 'Prof. Dr. Mircea Olteanu', 010464 Bucharest, Romania.; Serban D; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Tudor C; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Stoica PL; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Nedea MI; Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Dumitrescu D; Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Source: Journal of clinical medicine [J Clin Med] 2026 Jan 21; Vol. 15 (2). Date of Electronic Publication: 2026 Jan 21.
Publication Type: Journal Article; Review
Language: English
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
Imprint Name(s): Original Publication: Basel, Switzerland : MDPI AG, [2012]-
Abstract: Background/Objectives: Infectious keratitis remains a major cause of blindness worldwide, and many cases progress to therapeutic keratoplasty despite advances in antimicrobial therapy. This systematic review aims to evaluate the outcomes of therapeutic keratoplasty in microbial keratitis and examine factors influencing anatomical success, graft survival, and visual rehabilitation. Methods: A systematic review was conducted following PRISMA guidelines, including English-language studies, published between 2000 and 2025. Studies with ≥10 eyes and ≥6 months follow-up were included. Data on infection control, graft clarity, anatomical success, visual acuity, and complications were extracted. Results: Fourteen studies encompassing 1527 eyes were analyzed. TPK accounted for 89% of procedures; DALK was used selectively for anterior or mid-stromal infections. Overall infection control ranged from 69 to 100%, with globe preservation in 85-100% of cases. Bacterial keratitis had higher cure rates and graft clarity than fungal or Acanthamoeba keratitis. Larger grafts (>8 mm) and deep stromal involvement were associated with increased graft rejection and postoperative complications. DALK offered higher graft survival and lower immunologic risk when the endothelium was spared. Visual outcomes were generally limited, reflecting preoperative disease severity, timing of surgery, and postoperative immunomodulation constraints. Early surgical intervention improved anatomical outcomes in severe fungal keratitis. Conclusions: Therapeutic keratoplasty is an effective globe-preserving intervention in advanced microbial keratitis, but with limited functional outcomes. Further prospective studies are needed to refine surgical indications, postoperative management, and long-term functional results.
References: Eur J Ophthalmol. 2022 Jan;32(1):170-175. (PMID: 33183081); Pharmaceutics. 2023 Mar 29;15(4):. (PMID: 37111577); Microorganisms. 2024 Aug 30;12(9):. (PMID: 39338475); BMJ. 2021 Mar 29;372:n71. (PMID: 33782057); Am J Ophthalmol. 2008 Jan;145(1):130-5. (PMID: 17996208); Chirurgia (Bucur). 2018 Sept-Oct;113(5):651-667. (PMID: 30383992); Int J Ophthalmol. 2023 Jul 18;16(7):1065-1070. (PMID: 37465508); Eye (Lond). 2017 Dec;31(12):1639-1646. (PMID: 29192684); Indian J Med Res. 2019 Jul;150(1):7-22. (PMID: 31571625); Indian J Ophthalmol. 2020 Mar;68(3):442-446. (PMID: 32056998); Clin Ophthalmol. 2020 Dec 21;14:4451-4457. (PMID: 33376299); Int Ophthalmol. 2017 Oct;37(5):1085-1093. (PMID: 27723008); BMC Infect Dis. 2024 Mar 4;24(1):276. (PMID: 38438857); Ophthalmology. 2014 Jul;121(7):1377-82. (PMID: 24576886); Clin Ophthalmol. 2015 Dec 07;9:2299-304. (PMID: 26673279); Indian J Ophthalmol. 2024 Apr 1;72(4):483-488. (PMID: 38146983); Diagnostics (Basel). 2023 Aug 11;13(16):. (PMID: 37627913); Infect Drug Resist. 2019 Aug 12;12:2487-2493. (PMID: 31496763); BMC Ophthalmol. 2018 May 3;18(1):112. (PMID: 29724209); Cornea. 2023 Nov 1;42(11):1333-1339. (PMID: 38112645); Am J Ophthalmol. 2007 May;143(5):755-762. (PMID: 17335767); J Pharm Anal. 2025 Sep;15(9):101250. (PMID: 41050117); J Curr Ophthalmol. 2018 Apr 26;30(4):315-320. (PMID: 30555963); CLAO J. 2002 Jul;28(3):111-8. (PMID: 12144228); Indian J Ophthalmol. 2009 Jul-Aug;57(4):273-9. (PMID: 19574694); J Clin Med. 2025 May 03;14(9):. (PMID: 40364196); Ophthalmology. 2014 Jul;121(7):1383-8. (PMID: 24630688); Am J Ophthalmol Case Rep. 2022 Jan 27;25:101372. (PMID: 35198803); J Clin Med. 2025 Aug 25;14(17):. (PMID: 40943747); JAMA Ophthalmol. 2022 Feb 01;140(2):179-184. (PMID: 35024776); Ophthalmology. 2009 Apr;116(4):615-23. (PMID: 19243833); Int Ophthalmol. 2024 Nov 10;44(1):421. (PMID: 39522099); Eye (Lond). 2021 Apr;35(4):1084-1101. (PMID: 33414529); JBI Evid Synth. 2020 Oct;18(10):2127-2133. (PMID: 33038125); J Formos Med Assoc. 2020 Jun;119(6):1061-1069. (PMID: 31635845); Cont Lens Anterior Eye. 2023 Aug;46(4):101844. (PMID: 37117130); Ophthalmology. 2024 Mar;131(3):277-287. (PMID: 37802392); Am J Ophthalmol. 2004 Apr;137(4):736-43. (PMID: 15059714); Clin Ophthalmol. 2022 Jul 12;16:2245-2254. (PMID: 35855739); Med J Armed Forces India. 2008 Jan;64(1):40-2. (PMID: 27408078); Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6273-6281. (PMID: 29242901); Cureus. 2022 Oct 30;14(10):e30866. (PMID: 36465768); Int J Ophthalmol. 2012;5(6):698-703. (PMID: 23275903); J Clin Med. 2025 Apr 07;14(7):. (PMID: 40217976); JAMA Ophthalmol. 2017 Sep 1;135(9):987-991. (PMID: 28817744); Indian J Ophthalmol. 2019 Oct;67(10):1599-1605. (PMID: 31546488); Int Ophthalmol. 2020 Dec;40(12):3513-3519. (PMID: 32737730); Arch Soc Esp Oftalmol (Engl Ed). 2025 Jan;100(1):28-36. (PMID: 39566599); Clin Exp Ophthalmol. 2024 May-Jun;52(4):402-415. (PMID: 38267255); Biology (Basel). 2023 Dec 05;12(12):. (PMID: 38132315)
Contributed Indexing: Keywords: Acanthamoeba keratitis; bacterial keratitis; deep anterior lamellar keratoplasty; fungal keratitis; graft survival; infectious keratitis; penetrating keratoplasty; therapeutic keratoplasty; visual recovery
Entry Date(s): Date Created: 20260128 Date Completed: 20260128 Latest Revision: 20260131
Update Code: 20260131
PubMed Central ID: PMC12842231
DOI: 10.3390/jcm15020871
PMID: 41598806
Database: MEDLINE

Journal Article; Review